Drug Safety Newsletter 44th Edition
19 October 2011
Topics covered in this edition of the newsletter include:
• Multaq (dronedarone) – Restriction of use and new monitoring requirements
• MabThera (rituximab) – Association with fatal infusion related reactions in patients with rheumatoid arthritis
• Non-prescription cough and cold medicines for young children – New advice
• Vimpat 15 mg/ml syrup (lacosamide) – Discontinuation of supply
• Direct Healthcare Professional Communications published on the IMB website since the last Drug Safety Newsletter
Drug Safety Newsletter 44th Edition